Treatment of Chlamydia in Females with Acne
Treat the chlamydial infection with azithromycin 1 g orally as a single dose or doxycycline 100 mg orally twice daily for 7 days, recognizing that doxycycline serves dual purposes by treating both the chlamydia and potentially improving acne, though the chlamydia treatment takes priority. 1, 2
First-Line Treatment Approach
The presence of acne does not alter standard chlamydia treatment protocols, but creates a therapeutic opportunity:
- Azithromycin 1 g orally as a single dose is the preferred option when compliance is uncertain, offering 97% efficacy with directly observed therapy possible 1, 2
- Doxycycline 100 mg orally twice daily for 7 days provides the advantage of treating both conditions simultaneously, as it has established efficacy for both chlamydial infections (98% cure rate) and acne vulgaris 1, 2, 3
Clinical Decision-Making Algorithm
Choose doxycycline when:
- The patient has moderate-to-severe inflammatory acne requiring systemic antibiotic therapy 3
- Compliance with a 7-day regimen can be reasonably assured 1
- Cost is a significant consideration (doxycycline is less expensive than azithromycin) 2, 4
Choose azithromycin when:
- Compliance with multi-day regimens is questionable 1, 2
- The patient has erratic health-care-seeking behavior 2
- Immediate, directly observed single-dose therapy is needed 1
- The acne is mild and does not require systemic antibiotic therapy 3
Critical Contraindications
- Do not use doxycycline if the patient is pregnant - it is absolutely contraindicated 1, 2
- For pregnant patients, use azithromycin 1 g orally as a single dose or amoxicillin 500 mg orally three times daily for 7 days 1, 2
Implementation Best Practices
- Dispense medications on-site when possible and directly observe the first dose to maximize compliance 1, 2
- Instruct patients to abstain from sexual intercourse for 7 days after single-dose therapy or until completion of the 7-day regimen 1, 2
- Ensure all sex partners from the previous 60 days are evaluated, tested, and treated 1, 2
Follow-Up Considerations
- Test-of-cure is not routinely recommended unless compliance is questionable, symptoms persist, or reinfection is suspected 2, 4
- Consider retesting approximately 3 months after treatment due to high reinfection risk in women (39% in some adolescent populations) 5, 2
- Treatment failure rates are low: 0-3% for males and 0-8% for females with recommended regimens 5, 2
Common Pitfalls to Avoid
- Do not prioritize acne treatment over chlamydia eradication - the sexually transmitted infection carries greater morbidity risk including infertility and ectopic pregnancy 6
- Do not use topical clindamycin or erythromycin for acne as substitutes for systemic chlamydia treatment - these do not achieve adequate systemic levels for chlamydial eradication 3
- Avoid erythromycin as first-line therapy due to poor compliance from gastrointestinal side effects 2
Alternative Regimens
If first-line options cannot be used: